Close

Search

Search Menu
Photonics Media Photonics Marketplace Photonics Spectra BioPhotonics EuroPhotonics Vision Spectra Photonics Showcase Photonics ProdSpec Photonics Handbook

Where Does OCT Go From Here?

Facebook Twitter LinkedIn Email Comments

Ophthalmology remains the primary application, but promising new uses in cardiology and dermatology are on the horizon.

MARCIA STAMELL, ASSOCIATE MANAGING EDITOR, marcia.stamell @photonics.com

OCT-A — optical coherence tomography angioplasty — which allows imaging without dye, is a promising breakthrough in the detection of early-stage glaucoma. And swept-source OCT has opened new possibilities for diagnosing diabetic retinopathy and early macular degeneration. Although ophthalmology continues to dominate the OCT landscape, this imaging technology also has seen new adaptations outside that field. In dermatology, it is used for the diagnosis and treatment of nonmelanoma skin cancer, and in cardiology it’s being used for intravascular imaging. An OCT-A...Read full article

Related content from Photonics Media



    ARTICLES


    PRODUCTS


    PHOTONICS HANDBOOK ARTICLES


    WHITEPAPERS


    WEBINARS


    PHOTONICS DICTIONARY TERMS


    MEDIA


    PHOTONICS BUYERS' GUIDE CATEGORIES


    COMPANIES

    back to top
    Facebook Twitter Instagram LinkedIn YouTube RSS
    ©2020 Photonics Media, 100 West St., Pittsfield, MA, 01201 USA, [email protected]

    Photonics Media, Laurin Publishing
    x Subscribe to BioPhotonics magazine - FREE!
    We use cookies to improve user experience and analyze our website traffic as stated in our Privacy Policy. By using this website, you agree to the use of cookies unless you have disabled them.